Adalimumab 40mg Injection is a type of biologic medicine used to treat a variety of chronic inflammatory diseases, including rheumatoid arthritis and psoriasis. Unlike other biologics that are used to treat these diseases, adalimumab is injected directly into the subcutaneous (just under the skin) tissue. This type of delivery allows the medicine to quickly provide the necessary immune-modulating effects needed to reduce the inflammation associated with these diseases.
Uses of Adalimumab 40mg Injection
Adalimumab works by blocking the action of tumor necrosis factor alpha (TNF-α), which is an important mediator of inflammation. Blocking TNF-α can reduce inflammation, pain, and other symptoms of rheumatoid arthritis and psoriasis, such as joint pain and stiffness, skin rashes, swelling, and redness. By doing so, adalimumab may also prevent or slow joint damage in people with rheumatoid arthritis. In addition, because TNF-α is involved in other inflammatory diseases, such as Crohn’s disease and ankylosing spondylitis, adalimumab may also be used to treat these conditions.
Side Effects of Adalimumab 40mg Injection
A common side effect associated with adalimumab is injection site reactions, including redness, swelling, itching, pain, and rash. Other potential side effects include headache, anxiety, and flu-like symptoms. It is recommended to keep the injection site clean and dry, and to avoid using tight fitting clothes or massaging the site. Women should also be aware that this medicine may increase their risk of developing a serious infection, such as tuberculosis.
Adalimumab is typically administered once every two weeks, although this may vary depending on the specific condition being treated. It is important to follow the instructions given by your physician to ensure proper and effective use of this medicine.
In summary, Adalimumab 40mg Injection is a biologic medicine used to treat a variety of chronic inflammatory diseases, such as rheumatoid arthritis and psoriasis. It works by blocking a specific mediator of inflammation, TNF-α. Potential side effects include injection site reactions, headache, anxiety, and flu-like symptoms. Adalimumab is usually administered once every two weeks, and it is important to follow the instructions given by your healthcare provider.